Growth Metrics

Albemarle (ALB) EBIT (2016 - 2025)

Albemarle (ALB) has disclosed EBIT for 17 consecutive years, with -$600.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 534.36% year-over-year to -$600.3 million, compared with a TTM value of -$415.4 million through Dec 2025, up 34.88%, and an annual FY2025 reading of -$367.1 million, up 79.34% over the prior year.
  • EBIT was -$600.3 million for Q4 2025 at Albemarle, down from $117.6 million in the prior quarter.
  • Across five years, EBIT topped out at $1.1 billion in Q1 2023 and bottomed at -$1.4 billion in Q4 2023.
  • Average EBIT over 5 years is $53.3 million, with a median of $82.6 million recorded in 2025.
  • The sharpest move saw EBIT surged 577.43% in 2022, then crashed 534.36% in 2025.
  • Year by year, EBIT stood at -$31.3 million in 2021, then surged by 2947.85% to $891.0 million in 2022, then crashed by 255.47% to -$1.4 billion in 2023, then skyrocketed by 109.98% to $138.2 million in 2024, then plummeted by 534.36% to -$600.3 million in 2025.
  • Business Quant data shows EBIT for ALB at -$600.3 million in Q4 2025, $117.6 million in Q3 2025, and $47.5 million in Q2 2025.